86.4 F
Miami
Tuesday, May 24, 2022

Biogen extends losses as Wall Street weighs in on Medicare decision on Aduhelm

Biogen (BIIB) has extended post-market losses to trade ~9.9% lower in early trading after the U.S

Source

Related Articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

one × 2 =

Latest Articles